PL2590521T3 - Kompozycja odżywcza do stymulacji syntezy białek mięśniowych - Google Patents

Kompozycja odżywcza do stymulacji syntezy białek mięśniowych

Info

Publication number
PL2590521T3
PL2590521T3 PL11736184T PL11736184T PL2590521T3 PL 2590521 T3 PL2590521 T3 PL 2590521T3 PL 11736184 T PL11736184 T PL 11736184T PL 11736184 T PL11736184 T PL 11736184T PL 2590521 T3 PL2590521 T3 PL 2590521T3
Authority
PL
Poland
Prior art keywords
stimulation
protein synthesis
nutritional composition
muscle protein
muscle
Prior art date
Application number
PL11736184T
Other languages
English (en)
Inventor
Marion-Eve Adeline Jourdan
Yvette Charlotte Luiking
George Verlaan
Borg Sovianne Ter
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43797831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2590521(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL2590521T3 publication Critical patent/PL2590521T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0614—Citrulline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0628—Leucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds
    • A23V2250/306—Creatine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/71—Vitamin D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11736184T 2010-07-07 2011-07-06 Kompozycja odżywcza do stymulacji syntezy białek mięśniowych PL2590521T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2010/050436 WO2012005568A1 (en) 2010-07-07 2010-07-07 Nutritional composition for the stimulation of muscle protein synthesis
EP11736184.0A EP2590521B1 (en) 2010-07-07 2011-07-06 Nutritional composition for the stimulation of muscle protein synthesis

Publications (1)

Publication Number Publication Date
PL2590521T3 true PL2590521T3 (pl) 2017-08-31

Family

ID=43797831

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11736184T PL2590521T3 (pl) 2010-07-07 2011-07-06 Kompozycja odżywcza do stymulacji syntezy białek mięśniowych

Country Status (10)

Country Link
US (2) US20130210780A1 (pl)
EP (2) EP2590521B1 (pl)
CN (1) CN103079415B (pl)
BR (1) BR112013000446B1 (pl)
DK (1) DK2590521T3 (pl)
ES (1) ES2622116T3 (pl)
HU (1) HUE032597T2 (pl)
PL (1) PL2590521T3 (pl)
PT (1) PT2590521T (pl)
WO (2) WO2012005568A1 (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
JP2015513904A (ja) * 2012-03-26 2015-05-18 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養断片、タンパク質、および方法
RU2014143029A (ru) 2012-03-26 2016-05-20 Проньютриа, Инк. Заряженные питательные белки и способы их применения
WO2013148325A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
WO2013148328A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive proteins and methods
FR2996420B1 (fr) * 2012-10-09 2015-05-29 Internat Nutrition Res Company Produit dietetique destine a etre administre a long terme aux personnes obeses operees en chirurgie bariatrique
US9597367B2 (en) 2013-04-19 2017-03-21 Bioventures, Llc Methods for improving muscle and heart function
BR112015030767B1 (pt) * 2013-06-10 2021-03-30 N.V. Nutricia Uso de uma composição
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
EP3054938A1 (en) 2013-10-09 2016-08-17 Nestec S.A. Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
NL2015032B1 (en) * 2015-06-26 2017-01-24 Vitalnext B V Compositions and methods for the treatment of malnutrition.
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
US10188135B2 (en) 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
EP3851114B1 (en) * 2015-11-20 2024-10-09 Société des Produits Nestlé S.A. Composition comprising micellar whey protein, vitamin d and calcium for use in decreasing fat deposition in skeletal muscle in an elderly individual
EP3393274B1 (en) * 2015-12-24 2019-09-25 OrgaNext Life Science B.V. High protein nutritional product
EP3711493A1 (en) * 2016-11-16 2020-09-23 Fresenius Kabi Deutschland GmbH Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients
CN106616980B (zh) * 2016-12-07 2021-02-12 北京康比特体育科技股份有限公司 促进力量训练后肌肉合成的组合物及其制备方法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CA3043271A1 (en) * 2017-01-11 2018-07-19 Nestec S.A. Heat sterilized high protein spoonable nutritional compositions with whey protein which comprises whey protein micelles and a source of casein
US11504413B2 (en) * 2017-03-03 2022-11-22 Exerkine Corporation Multi-nutrient composition
CN107348522A (zh) * 2017-08-14 2017-11-17 北京市营养源研究所 一种改善老年人运动系统功能的营养组合物及其制备方法
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
CN107397230A (zh) * 2017-08-21 2017-11-28 杭州特悘衡康生物科技有限公司 营养组合物、促进手术后肌肉恢复和蛋白质合成的配方食品及其应用
EP3703516A4 (en) 2017-11-02 2021-08-18 BioVentures, LLC USE OF AMINO ACID SUPPLEMENTATION FOR IMPROVED MUSCLE PROTEIN SYNTHESIS
WO2019158541A1 (en) 2018-02-14 2019-08-22 Frieslandcampina Nederland B.V. Nutritional compositions for musculoskeletal support for athletes
WO2019204633A1 (en) * 2018-04-18 2019-10-24 Worlds Greatest Ingredients, LP Compositions and methods of use thereof to promote muscle growth and function
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
CN109077302A (zh) * 2018-07-18 2018-12-25 辰欣药业股份有限公司 一种治疗和预防老年肌肉衰减综合症的医用食品及其制备方法
CN109222103B (zh) * 2018-11-29 2021-04-20 汤臣倍健股份有限公司 增肌组合物和保健食品
CN109527585A (zh) * 2018-12-26 2019-03-29 浙江华康药业股份有限公司 一种能预防和缓解肌少症的营养组合物及其制备方法
CH715997A1 (de) * 2019-03-25 2020-09-30 Omanda Ag Proteingetränk und Darreichungseinheit zur Verabreichung von mit L-Leucin-angereicherten Molkenproteinkomponenten als Nahrungsanreicherung und dessen Herstellung.
EP3980002A1 (en) * 2019-06-07 2022-04-13 Société des Produits Nestlé S.A. Compositions and methods using one or more autophagy-inducing amino acids to potentiate musculoskeletal effect of one or more anabolic amino acids
CN110226756A (zh) * 2019-06-18 2019-09-13 山东理工大学 预防和缓解2型糖尿病患者肌少症的蛋白组件及制备方法
AU2021262720A1 (en) * 2020-04-27 2022-11-03 Leprino Performance Brands LLC Protein-fortified beverages for enhanced athletic performance
NL2025482B1 (en) * 2020-05-01 2021-11-18 Tassignon Holding B V Free BCAA chocolate products
EP4307923B1 (en) 2021-03-17 2025-06-25 N.V. Nutricia Liquid nutritional composition suitable for muscle function
IT202100007655A1 (it) * 2021-03-29 2022-09-29 Abiogen Pharma Spa Uso di colecalciferolo come coadiuvante nel trattamento di distrofie muscolari
CN117915788A (zh) * 2021-08-06 2024-04-19 N·V·努特里奇亚 用于肌肉质量、力量和功能的营养组合物
IT202300008709A1 (it) * 2023-05-03 2024-11-03 luigi rosario franco inderst Formulazione di vitamine idrosolubili, magnesio-L Pidolato e aminoacidi ramificati in forma levo gira (BCAA).

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
DE50312166D1 (de) * 2002-01-15 2010-01-14 Karl-Heinz Bauer Nahrungsergänzungsmittel
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
NZ546785A (en) 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
CA2577963C (en) 2004-08-25 2015-10-06 Mtor Formulations Ltd. Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
KR100549697B1 (ko) 2004-12-10 2006-02-07 김세규 무산소 상태에서 순간적인 임팩트 파워를 증대 시키는 아미노산 건강기능식품
FR2882896B1 (fr) * 2005-03-14 2007-05-04 Larena Sa Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees
BRPI0615396A2 (pt) 2005-08-26 2011-05-17 Nestec Sa composição nutricional para a prevenção ou tratamento de má-nutrição em um paciente obeso, bem como uso de uma fonte de proteìna, vitamina a, vitamina c, vitamina e, zinco e selênio para sua preparação
EP1774973A1 (en) 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
ITMI20052204A1 (it) * 2005-11-18 2007-05-19 Umberto Cornelli Uso di colostro per la profilassi delle sindroni influenzali
US8962678B2 (en) * 2006-07-05 2015-02-24 Kao Corporation Senescence inhibitor
JP2008013473A (ja) * 2006-07-05 2008-01-24 Kao Corp 筋機能低下抑制剤
FR2907011B1 (fr) 2006-10-17 2010-05-14 Univ Paris Descartes Utilisation de la citrulline pour le traitement des etats de denutrition
US20090042770A1 (en) 2007-01-14 2009-02-12 Bastian Eric D Branched Chain Amino Acid Chelate
US20080233245A1 (en) 2007-03-19 2008-09-25 Lesley Joan White Liquid nutrient composition for improving performance
JP4818177B2 (ja) * 2007-03-27 2011-11-16 ユニテックフーズ株式会社 高齢者向け骨・筋肉増強促進組成物
WO2009113845A1 (en) 2008-03-12 2009-09-17 N.V. Nutricia High protein liquid enteral nutritional composition
CA2723441A1 (en) 2008-05-21 2009-11-26 Stokely-Van Camp, Inc. Milk-based recovery beverage
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
CN102647990A (zh) 2009-07-20 2012-08-22 雀巢产品技术援助有限公司 减少功能状态损失的方法
WO2011078654A1 (en) 2009-12-24 2011-06-30 N.V. Nutricia Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
WO2012005568A1 (en) 2010-07-07 2012-01-12 N.V. Nutricia Nutritional composition for the stimulation of muscle protein synthesis
WO2012024611A1 (en) 2010-08-20 2012-02-23 Natural Alternatives International, Inc. Methods of treating sarcopenia and frailty
WO2012091542A1 (en) 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty

Also Published As

Publication number Publication date
EP2590521B1 (en) 2017-02-22
BR112013000446A2 (pt) 2016-05-03
WO2012005568A1 (en) 2012-01-12
WO2012005582A1 (en) 2012-01-12
US10045999B2 (en) 2018-08-14
CN103079415A (zh) 2013-05-01
HUE032597T2 (en) 2017-10-30
ES2622116T3 (es) 2017-07-05
PT2590521T (pt) 2017-05-02
EP3120716A1 (en) 2017-01-25
US20150290223A1 (en) 2015-10-15
DK2590521T3 (en) 2017-04-24
BR112013000446B1 (pt) 2019-10-29
EP2590521A1 (en) 2013-05-15
CN103079415B (zh) 2016-08-10
US20130210780A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
PL2590521T3 (pl) Kompozycja odżywcza do stymulacji syntezy białek mięśniowych
PL2515920T3 (pl) Niskokaloryczna wysokobiałkowa kompozycja odżywcza stymulująca syntezę białek mięśni
LT2580243T (lt) Antikūnai prieš žmogaus cd38
EP2555797A4 (en) TNF-ALPHA-BINDING PROTEINS
EP2649189A4 (en) TNF-ALPHA-BINDING PROTEINS
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
GB201012539D0 (en) Nutritional compositions
EP2579939A4 (en) STIMULATION OF NERVOUS TIBIALIS
ZA201209156B (en) Therapeutic oral composition
ZA201303175B (en) Human anti-tau antibodies
ZA201205432B (en) Compositions and methods for the diagnosis and treatment of tumor
ZA201303810B (en) Methods and compositions suitable for promoting healthy skin
EP2600727A4 (en) PREDIGERATED NUTRITION FORMULATION
PH12012501704A1 (en) Nutritional compositions
IL223292A0 (en) Stabilized human immunoglobulin composition
PL2294925T3 (pl) Mieszanka chipsów
ZA201208861B (en) Novel ruminant feed
ZA201207972B (en) Methods for enhancing the palatability of comestible compositions
IL223926A0 (en) Synthesis of cyclopentaquinazolines
GB201002318D0 (en) Dietary supplement composition
SI2555790T1 (sl) Terapevtska uporaba proteina beta2-mikroglobulina
PT2603319E (pt) Processo para a preparação de uretanos
EP2534963A4 (en) PROTEIN SYNTHESIS PROMOTERS
TWI560195B (en) Novel synthesis of 5-deoxy-5'-fluorocytidine compounds
ZA201209495B (en) Novel methods for the preparation of p2x7r antagonists